Travere Therapeutics, Inc. (TVTX) Stock Total Returns
Growth of $10,000 chart
2021-04-21 to 2026-04-21 to
$
%
%
Loading chart…
Investment Performance
Final Value
$14,990
Total Return
49.90%
CAGR
8.43%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +2.55% |
| Median | +0.53% |
| Best | +75.03% |
| Worst | -50.59% |
| % of Windows Positive | 51.3% |
1-Year (252 Trading Days)
| Average | +27.61% |
| Median | +5.19% |
| Best | +295.63% |
| Worst | -74.50% |
| % of Windows Positive | 51.3% |
3-Year (756 Trading Days)
| Average | -12.29% |
| Median | -30.77% |
| Best | +108.49% |
| Worst | -78.93% |
| % of Windows Positive | 27.9% |
Risk Metrics
| Maximum Drawdown | -83.12% |
| Average Drawdown | -38.08% |
| Drawdown Duration | 966 Trading Days |
| Sortino Ratio | 0.68 |
| Calmar Ratio | 0.10 |
| CVaR (5%) | -8.82% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +1.49% (+4.99% ann.) | +$149.18 | $0.00 | $0.00 | $0.00 |
| 2025 | +119.35% | +$11934.56 | $0.00 | $0.00 | $0.00 |
| 2024 | +93.77% | +$9377.09 | $0.00 | $0.00 | $0.00 |
| 2023 | -57.25% | $5725.15 | $0.00 | $0.00 | $0.00 |
| 2022 | -32.25% | $3224.87 | $0.00 | $0.00 | $0.00 |
| 2021 | +13.89% | +$1388.74 | $0.00 | $0.00 | $0.00 |
| 2020 | +91.94% | +$9193.66 | $0.00 | $0.00 | $0.00 |
| 2019 | -37.25% | $3725.14 | $0.00 | $0.00 | $0.00 |
| 2018 | +7.40% | +$740.39 | $0.00 | $0.00 | $0.00 |
| 2017 | +11.30% | +$1130.48 | $0.00 | $0.00 | $0.00 |
| 2016 | -1.87% | $186.63 | $0.00 | $0.00 | $0.00 |
| 2015 | +57.60% | +$5759.81 | $0.00 | $0.00 | $0.00 |
| 2014 | +74.86% | +$7485.71 | $0.00 | $0.00 | $0.00 |
| 2013 | +108.96% | +$10895.53 | $0.00 | $0.00 | $0.00 |
| 2012 partial | +123.33% (+25298.98% ann.) | +$12333.33 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | November 8, 2012 – February 19, 2020 | +1024.00% | +39.42% | +$102400.00 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -37.19% | -99.51% | $3719.44 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +80.35% | +158.29% | +$8035.12 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +25.64% | +24.18% | +$2563.99 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 8, 2022 | -26.41% | -27.86% | $2640.98 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -34.87% | -20.65% | $3487.11 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 21, 2026 | +170.24% | +87.02% | +$17024.39 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.